Can perioperative pCO 2 gaps predict complications in patients undergoing major elective abdominal surgery randomized to goal-directed therapy or standard care? A secondary analysis.
Ilonka N de KeijzerThomas KaufmannEric E C de WaalMichael FrankDianne de Korte-de BoerLeonard M MontenijWolfgang F F A BuhreThomas W L ScheerenPublished in: Journal of clinical monitoring and computing (2024)
The difference between venous and arterial carbon dioxide pressure (pCO 2 gap), has been used as a diagnostic and prognostic tool. We aimed to assess whether perioperative pCO 2 gaps can predict postoperative complications. This was a secondary analysis of a multicenter RCT comparing goal-directed therapy (GDT) to standard care in which 464 patients undergoing high-risk elective abdominal surgery were included. Arterial and central venous blood samples were simultaneously obtained at four time points: after induction, at the end of surgery, at PACU/ICU admission, and PACU/ICU discharge. Complications within the first 30 days after surgery were recorded. Similar pCO 2 gaps were found in patients with and without complications, except for the pCO 2 gap at the end of surgery, which was higher in patients with complications (6.0 mmHg [5.0-8.0] vs. 6.0 mmHg [4.1-7.5], p = 0.005). The area under receiver operating characteristics curves for predicting complications from pCO 2 gaps at all time points were between 0.5 and 0.6. A weak correlation between ScvO 2 and pCO 2 gaps was found for all timepoints (ρ was between - 0.40 and - 0.29 for all timepoints, p < 0.001). The pCO 2 gap did not differ between GDT and standard care at any of the selected time points. In our study, pCO 2 gap was a poor predictor of major postoperative complications at all selected time points. Our research does not support the use of pCO 2 gap as a prognostic tool after high-risk abdominal surgery. pCO 2 gaps were comparable between GDT and standard care. Clinical trial registration Netherlands Trial Registry NTR3380.
Keyphrases
- patients undergoing
- healthcare
- clinical trial
- palliative care
- risk factors
- minimally invasive
- quality improvement
- carbon dioxide
- double blind
- cardiac surgery
- open label
- phase ii
- phase iii
- emergency department
- coronary artery bypass
- mechanical ventilation
- acute coronary syndrome
- coronary artery disease
- acute kidney injury
- chronic pain
- extracorporeal membrane oxygenation
- percutaneous coronary intervention
- smoking cessation
- health insurance
- replacement therapy